November/December 2007 Issue


  • Therapeutic Dose: The Perfect Storm

    (Financial pressures + regulatory changes) = new manufacturing paradigm (- breadth of experience + narrow focus) = problems achieving Quality by Design.

  • Respondents Short-Sighted in Lean Survey

    Managers might be expecting the wrong near-term results when it comes to the benefits of lean manufacturing, resulting in apathy. A recent lean production survey conducted by Lean Enterprise Institute (LEI) found that cutting costs was rated as the top benefit to the process by managers and executives.

  • The Ups and Downs of Taking the Bus

    In this two-part series, Wyeth's Gary Forrest discusses the challenges and benefits of implementing fieldbus technologies at a new bioprocess development facility.

  • Wyeth’s Charlie Portwood: Focus on QbD Before ICH Q 8-10

    After his keynote speech at the ISPE meeting in Las Vegas this week, Charlie Portwood, president of Technical Operations and Product Supply at Wyeth Pharmaceuticals, shared his views on pharma’s supply chain management and quality.

  • New Patterns for Quality

    Quality by Design is breathing new life into quality systems and process analytical technology.